{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Bates MN"],"pubmed_abstract":["<h4>Objective</h4>Nonfatal overdoses provide critical insights into the substance use crisis, offering opportunities for timely interventions and prevention. This study pilots a nonfatal overdose biosurveillance strategy to analyze the demographic, clinical, and toxicological profiles of overdose patients, aiming to identify patterns and risk factors associated with these incidents.<h4>Methods</h4>We assessed residual urine specimens collected from emergency department patients experiencing a nonfatal overdose at 2 hospitals in Wisconsin from August 2022 through February 2024. We collected data on patient demographic characteristics, results of clinical toxicology screening, manner of overdose, risk factors for overdose, and discharge status. Statistical analyses identified associations an"],"journal":["Public health reports (Washington, D.C. : 1974)"],"pagination":["333549251358671"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12432015"],"repository":["biostudies-literature"],"pubmed_title":["Nonfatal Overdose Biosurveillance: A Cross-Sectional Pilot Study."],"pmcid":["PMC12432015"],"pubmed_authors":["Barkholtz HM","Burmeister B","Murphy C","Jin Z","Bates MN"],"additional_accession":[]},"is_claimable":false,"name":"Nonfatal Overdose Biosurveillance: A Cross-Sectional Pilot Study.","description":"<h4>Objective</h4>Nonfatal overdoses provide critical insights into the substance use crisis, offering opportunities for timely interventions and prevention. This study pilots a nonfatal overdose biosurveillance strategy to analyze the demographic, clinical, and toxicological profiles of overdose patients, aiming to identify patterns and risk factors associated with these incidents.<h4>Methods</h4>We assessed residual urine specimens collected from emergency department patients experiencing a nonfatal overdose at 2 hospitals in Wisconsin from August 2022 through February 2024. We collected data on patient demographic characteristics, results of clinical toxicology screening, manner of overdose, risk factors for overdose, and discharge status. Statistical analyses identified associations an","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-01T15:57:02.882Z","creation":"2026-04-08T13:56:24.292Z"},"accession":"S-EPMC12432015","cross_references":{"pubmed":["40937595"],"doi":["10.1177/00333549251358671"]}}